Local biotechnology firms then match public funding ... About 50 miles south of San Francisco in Palo Alto, Stanford is also expanding its biomedical/bioscience research with the “Bio-X ...

For decades, the U.S. biotech industry has thrived in hubs such as Boston-Cambridge and the San Francisco Bay Area, fueled by ...

Biotechnology has enormous potential to solve ... Before founding TeselaGen, Mike Fero, Nathan Hillson, and Abeliuk were working at Stanford University, spending a lot of time on tasks that ...

Director of the US-Asia Technology Management Center at Stanford University; Marietta Wu, Managing Director of Quan Capital; and Mika Nishimura, Operational Partner of Glide Healthcare. Dr. Kelly ...

Stanford University genetics professor Dr. Stanley Cohen paid $29.2 million to settle a lawsuit over misleading claims he made about Nuredis Inc., his now-dissolved biotechnology company.

A prominent genetics professor at Stanford University in the US has paid $29 million to investors in Nuredis – a biotech that has now been wound up – after a California court found he ...

Promising biotech companies could become attractive ... Vera Therapeutics (NASDAQ:VERA) later announced a licensing agreement with Stanford University for VT-109, a fusion protein designed to ...

Morningstar brands and products Company Portfolio ...